Preferences help
enabled [disable] Abstract
Number of results
2014 | 9 | 5 | 625-631
Article title

Prognostic value of serum cystatin C levels in cirrhotic patients with normal serum creatinine

Title variants
Languages of publication
Physical description
1 - 10 - 2014
31 - 7 - 2014
  • Gatroenterology and Hepatology Department Bulgaria, Medical University-Plovdiv, 4000, Plovdiv, Bulgaria
  • Plovdiv, Faculty of Biology Bulgaria, University of Plovdiv „Paisii Hilendarski”, 4000, Plovdiv, Bulgaria
  • [1] Garcia-Tsao G., Parikh C.R., Viola A. Acute kidney injury in cirrhosis. Hepatology, 2008, 48, 2064–2077[Crossref]
  • [2] Arroyo V., Colmenero J. Ascites and hepatorenal syndrome in cirrhosis. J. Hepatol., 2003, 38, 69–89[Crossref]
  • [3] Arroyo V., Fernandez J., Gines P. Pathogenesis and treatment of hepatorenal syndrome. Semin. Liver Dis., 2008, 28, 81–95[Crossref][WoS]
  • [4] Cholongitas E., Shusang V., Marelli L., Nair D., Thomas M., Patch D., Burns A., Sweny P., Burroughs A.K. Review article: renal function assessment in cirrhosis - difficulties and alternative measurements. Aliment. Pharmacol. Ther., 2007, 26, 969–971[Crossref][WoS]
  • [5] Lopez-Hoyos M., San Segundo D., Benito M.J., Fernández-Fresnedo G., Ruiz J.C., Rodrigo E., Gómez-Alamillo C., Benito A., Arias M. Association between serum soluble CD30 and serum creatinine before and after renal transplantation. Transplant. Proc., 2008, 40, 2903–2905[Crossref]
  • [6] Mishra J., Ma Q., Prada A., Mitsnefes M., Yang J., Barasch J., Devarajan P. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J. Am. Soc. Nephrol., 2003,14, 2534–2543[Crossref]
  • [7] Parikh C.R., Abraham E., Ancukiewicz M., Edelstein C.L. Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J. Am. Soc. Nephrol., 2005, 16, 3046–3052[Crossref]
  • [8] Bonventre J.V. Diagnosis of acute kidney injury: from classic parameters to new biomarkers. Contrib. Nephrol., 2007, 156, 213–219[Crossref]
  • [9] Newman D.J., Thakkar H., Edwards R.G., Wilkie M., White T., Grubb A.O., Price C.P. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int.,1995,47, 312–318[Crossref]
  • [10] Randers E., Erlandsen E.J. Serum cystatin C as an endogenous marker of the renal function-a review. Clin. Chem. Lab. Med., 1999, 37, 389–395[Crossref]
  • [11] Demirtas S., Bozbas A., Akbay A., Akbay A., Yavuz Y., Karaca L. Diagnostic value of serum cystatin C for evaluation of hepatorenal syndrome. Clin. Chim. Acta, 2001, 311, 81–89[Crossref]
  • [12] Gerbes A.L., Gulberg V., Bilzer M., Vogeser M. Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of the liver. Gut, 2002, 50, 106–110[Crossref]
  • [13] Orlando R., Mussap M., Plebani M., Piccoli P., De Martin S., Floreani M., Padrini R., Palatini P. Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis. Clin. Chem., 2002, 48, 850–858
  • [14] Kim D.J., Kang H.S., Choi H.S., Cho H.J., Kim S.E., Keum B., An H., Kim J.H., Seo S.Y., Kim Y.S., Yim H.J., Jeen Y.T., Lee H.S., Um S.H., Kim C.D., Ryu H.S. Serum cystatin c level is a useful marker for the evaluation of renal function in patients with cirrhotic ascites and normal serum creatinine levels. The Korean Journal of Hepatology, 2011,17,130–138[Crossref]
  • [15] Chung M.Y., Jun D.W., Sung S.A. Diagnostic value of cystatin C for predicting acute kidney injury in patients with liver cirrhosis. The Korean Journal of Hepatology,2010, 16, 301–307[Crossref]
  • [16] Ix J.H., Shlipak M.G., Chertow G.M., Whooley M.A. Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study. Circulation, 2007,115,173–179[Crossref]
  • [17] De Boer I.H., Katz R., Cao J.J., Fried L.F., Kestenbaum B., Mukamal K., Rifkin D.E., Sarnak M.J., Shlipak M.G., Siscovick D.S. Cystatin C, albuminuria, and mortality among older adults with diabetes. Diabetes Care, 2009, 32,1833–1838 [Crossref]
  • [18] Pugh R.N., Murray-Lyon I.M., Dawson J.L., Pietroni M.C., Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br. J. Surg., 1973, 60, 646–649[Crossref]
  • [19] Wiesner R., Edwards E., Freeman R., Harper A., Kim R., Kamath P., Kremers W., Lake J., Howard T., Merion R.M., Wolfe R.A., Krom R. Model for end-stage liver disease MELD and allocation of donor livers. Gastroenterology 2003,124, 91–96[Crossref]
  • [20] Cockcroft D.W., Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron, 1976, 16, 31–41[Crossref]
  • [21] Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann. Intern. Med., 1999, 130, 461–470[Crossref]
  • [22] Proulx N.L., Akbari A., Garg A.X., Rostom A., Jaffey J., Clark H.D. Measured creatinine clearance from timed urine collections substantially overestimates glomerular filtration rate in patients with liver cirrhosis: a systematic review and individual patient meta-analysis. Nephrol. Dial. Transplant,2005,20,1617–1622[Crossref]
  • [23] Seo Y.S., Jung E.S., An H., Kim J.H., Jung Y.K., Kim J.H., Yim H.J., Yeon J.E., Byun K.S., Kim C.D., Ryu H.S., Um S.H. Serum cystatin C level is a good prognostic marker in patients with cirrhotic ascites and normal serum creatinine levels. Liver Int.,2009,29,1521–1527[Crossref][WoS]
  • [24] Fernández-Esparrach G., Sánchez-Fueyo A., Ginès P., Uriz J., Quinto L., Ventura P.J., Cardenas A., Guevara M., Sort P., Jimenez W., Bataller R., Arroyo V., Rodes J. A prognostic model for predicting survival in cirrhosis with ascites. J. Hepatol., 2001, 34, 46–52[Crossref]
  • [25] Longheval G., Vereerstraeten P., Thiry P., Delhaye M., Le Moine O., Deviere J., Bourgeois N., Adler M. Predictive models of short- and long-term survival in patients with nonbiliary cirrhosis. Liver Transpl., 2003, 9, 260–267[Crossref]
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.